Cormorant Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-500,000
| Closed | -$27M | – | 56 |
|
|
2017
Q3 | $27M | Sell |
500,000
-400,000
| -44% | -$21.6M | 4.77% | 6 |
|
|
2017
Q2 | $50.6M | Buy |
900,000
+300,000
| +50% | +$16.9M | 8.38% | 1 |
|
|
2017
Q1 | $23.5M | Buy |
600,000
+63,000
| +12% | +$2.47M | 3.41% | 9 |
|
|
2016
Q4 | $12.1M | Sell |
537,000
-59,000
| -10% | -$1.32M | 1.62% | 21 |
|
|
2016
Q3 | $13.5M | Buy |
596,000
+200,000
| +51% | +$4.54M | 1.49% | 24 |
|
|
2016
Q2 | $9.35M | Sell |
396,000
-304,000
| -43% | -$7.17M | 1.33% | 27 |
|
|
2016
Q1 | $14.3M | Buy |
700,000
+200,000
| +40% | +$4.08M | 2.15% | 13 |
|
|
2015
Q4 | $25.7M | Hold |
500,000
| – | – | 3.08% | 8 |
|
|
2015
Q3 | $21.3M | Hold |
500,000
| – | – | 3.4% | 9 |
|
|
2015
Q2 | $22.8M | Sell |
500,000
-74,500
| -13% | -$3.39M | 3.03% | 10 |
|
|
2015
Q1 | $21.8M | Sell |
574,500
-25,500
| -4% | -$968K | 3.37% | 7 |
|
|
2014
Q4 | $17M | Buy |
600,000
+400,000
| +200% | +$11.3M | 2.62% | 12 |
|
|
2014
Q3 | $5.06M | Hold |
200,000
| – | – | 1.04% | 30 |
|
|
2014
Q2 | $5.84M | Hold |
200,000
| – | – | 1.55% | 23 |
|
|
2014
Q1 | $5.18M | Buy |
200,000
+125,000
| +167% | +$3.24M | 1.19% | 30 |
|
|
2013
Q4 | $1.93M | Buy |
+75,000
| New | +$1.93M | 0.56% | 29 |
|